Akerna Flash Report: 420 cannabis sales reach $154.4 million, setting a new record for most dollars spent in single day
Akerna (Nasdaq: KERN) reported record cannabis sales on April 20, 2022, reaching $154.4 million in a single day, marking a 38.1% increase from last year. The six-day period around the holiday generated total cannabis retail sales of $485.3 million across the US. Notably, women shoppers accounted for over 40% of the sales. The company's predictive analytics showed a -1.79% variance from projected sales. As cannabis legalization spreads, Akerna anticipates continued growth in market share and sales across demographics.
- Record cannabis sales of $154.4 million on April 20, 2022.
- Total cannabis retail sales of $485.3 million during the six-day period.
- 38.1% growth in sales compared to last year's 420 sales.
- Women's market share in cannabis sales exceeded 40%.
- None.
The six-day period around the holiday brought the total cannabis retail sales for the consumption occasion to
DENVER, April 26, 2022 /PRNewswire/ -- Akerna (Nasdaq: KERN), a leading enterprise software company and the developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today announced that April 20, 2022, broke all previous cannabis retail records, bringing in a total of
Compared to last year's 420, which until last week was the industry's largest sales day to date and brought in nearly
US National Retail Cannabis Sales:
Friday (4/15/22) | |
Saturday (4/16/22) | |
Sunday (4/17/22) | |
Monday (4/18/22) | |
Tuesday (4/19/22) | |
Wednesday (4/20/22) | |
Total: |
When looking at the period around 420, US shoppers spent a total of
"Using our historical Akerna data, we released a prediction report that the period around 420 would bring in a total of
Akerna data has shown increases in cannabis sales market share for women shoppers over the past few years. This trend continued with this 420, with women's market share of sales breaking the
As more markets legalize cannabis and more Americans become comfortable with the legal cannabis industry, these year-over-year increases are expected to continue. Data shows cannabis has a broad appeal to people of all demographics.
Other predicted values for the long "holiday" weekend (4/15 - 4/20)
- Category sales:
- Flower –
48.11% - Cartridge/Pens –
31.66% - Concentrates –
11.63% - Infused Edibles –
6.87% - Infused Non-Edible –
0.71% - Non-Medicated –
1.01%
Sales by demographic:
- Men -
59.93% - Women -
40.07%
Sales by age groups:
- Under 30 –
28.38% - 30-40 –
30.43% - 40-50 –
19.92% - 50-60 –
11.49% - Over 60 –
9.78%
About the Akerna Flash Report:
Flash Report looks at buying trends in the cannabis market as captured by Akerna's flagship solution, MJ Platform. MJ Platform includes MJ Analytics, allowing operators, investors, and regulators to access the industry's largest and most statistically relevant database to drive data-driven business decisions.
MJ Analytics provides:
- The most significant statistical relevance across countries
- Normalized data (not farmed from various disparate POS platforms)
- Complete cannabis supply chain data
- Business insights founded in category management methodology
MJ Analytics can eliminate the guesswork and provide answers to questions like:
- What is the gross margin return on inventory?
- What SKUs should be carried?
- How do basket adjacencies influence discounting and retention strategies?
- What does a medical market look like a year or five years after decriminalizing cannabis?
Click here for more information about MJ Platform and MJ Analytics.
Some instances of the flash report may include business intelligence derived from Akerna's family of companies, including Ample Organics, Leaf Data Systems, solo sciences, Trellis, Viridian Sciences, and 365 Cannabis. Sales projections are based on market adjustment calculations and aggregate the entire US market.
Akerna has one of the largest seed-to-sale footprints in the cannabis industry, operating in 15 countries and 23 US states, including Pennsylvania, Oklahoma, Puerto Rico, Arizona, California, Utah, Michigan, Colorado, Montana, Nevada, Maine, Vermont, New Mexico, Missouri, Texas, Ohio, Maryland, Washington DC, Kansas, Arkansas, New York.
Increases are relative to the prior period. Additional business intelligence data sources may include proprietary tools used by Akerna's family of companies.
About Akerna:
Akerna (Nasdaq: KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than
The Company's cornerstone technology, MJ Platform, one of the world's leading cannabis infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators. Akerna also offers a complete suite of professional consulting services and data analytics for businesses as well as solo sciences, Leaf Data Systems, Trellis, Ample Organics, Viridian Sciences and 365 Cannabis.
For more information, visit https://www.akerna.com/.
Forward-Looking Statements:
Certain statements made in this release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such terms or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding the ability of the MJ Platform team to help operators make decisions through analytics and reporting. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside Akerna's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include (i) Akerna's ability to maintain relationships with customers and suppliers and retain its management and key employees, (ii) changes in applicable laws or regulations, (iii) changes in the market place due to the coronavirus pandemic or other market factors, (iv) and other risks and uncertainties disclosed from time to time in Akerna's filings with the U.S. Securities and Exchange Commission, including those under "Risk Factors" therein. You are cautioned not to place undue reliance on forward-looking statements. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein. Forecasts and estimates regarding Akerna's industry and end markets are based on sources believed to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.
View original content to download multimedia:https://www.prnewswire.com/news-releases/akerna-flash-report-420-cannabis-sales-reach-154-4-million-setting-a-new--record-for-most-dollars-spent-in-single-day-301533049.html
SOURCE Akerna
FAQ
What were the cannabis retail sales on April 20, 2022 for KERN?
How much did Akerna predict for cannabis sales during the 420 holiday?
What is the significance of the $485.3 million total cannabis sales figure for KERN?
How did women's market share in cannabis sales change for KERN?
